Recursion Pharmaceuticals Inc Clas (RXRX)
Stock-Based Compensation
$19.50M
Quarterly · Period ending: · USD
RXRX Stock-Based Compensation
Latest reported$19.50Mperiod ending
Latest reported$19.50Mperiod ending
RXRX Quarterly Stock-Based Comp ($1.27M → $19.50M)
Quarterly stock-based compensation
High-resolution chart · PNG
RXRX stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 19,498,000 | |
| 22,215,000 | |
| 23,763,000 | |
| 25,243,000 | |
| 26,159,000 | |
| 36,058,000 | |
| 30,784,000 | |
| 18,253,000 | |
| 16,524,000 | |
| 16,127,000 | |
| 16,086,000 | |
| 16,792,000 | |
| 11,811,000 | |
| 8,814,000 | |
| 7,695,000 | |
| 8,907,000 | |
| 5,675,000 | |
| 5,632,000 | |
| 4,341,000 | |
| 3,363,000 | |
| 5,317,000 | |
| 1,821,000 | |
| 1,188,000 | |
| 1,070,000 | |
| 769,000 | |
| 1,265,000 |